Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Alzheimer's Disease

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    March 2010
  1. VELLAS B
    Tarenflurbil for Alzheimer's disease: a "shot on goal" that missed.
    Lancet Neurol. 2010;9:235-7.
    PubMed     Text format     Related articles   


    February 2010
  2. RINNE JO , Brooks DJ, Rossor MN, Fox NC, et al
    (11)C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.
    Lancet Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available


  3. GANDY S
    Testing the amyloid hypothesis of Alzheimer's disease in vivo.
    Lancet Neurol. 2010.
    PubMed     Text format     Related articles   


  4. MAYOR S
    Gordon Wilcock: taking risks to improve Alzheimer's care.
    Lancet Neurol. 2010;9:146.
    PubMed     Text format     Related articles   


  5. WILCOCK GK
    Bapineuzumab in Alzheimer's disease: where now?
    Lancet Neurol. 2010;9:134-6.
    PubMed     Text format     Related articles   


  6. BERGMANS BA , De Strooper B
    gamma-secretases: from cell biology to therapeutic strategies.
    Lancet Neurol. 2010;9:215-26.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  7. JACK CR JR , Knopman DS, Jagust WJ, Shaw LM, et al
    Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
    Lancet Neurol. 2010;9:119-28.
    PubMed     Text format     Related articles    Abstract available


  8. PETERSEN RC
    Alzheimer's disease: progress in prediction.
    Lancet Neurol. 2010;9:4-5.
    PubMed     Text format     Related articles   


    December 2009
  9. DARTIGUES JF
    Alzheimer's disease: a global challenge for the 21st century.
    Lancet Neurol. 2009;8:1082-3.
    PubMed     Text format     Related articles   


    November 2009
  10. PERICAK-VANCE MA , Haines JL
    Beyond proof of principle: new genes for Alzheimer's disease through collaboration.
    Lancet Neurol. 2009;8:977-9.
    PubMed     Text format     Related articles   


    July 2009
  11. GAUTHIER S
    Will CSF analysis become routine in people with memory complaints?
    Lancet Neurol. 2009;8:595-6.
    PubMed     Text format     Related articles   


    June 2009
  12. VISSER PJ , Verhey F, Knol DL, Scheltens P, et al
    Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Lancet Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available


  13. MAYOR S
    Bengt Winblad: coaching the team in Alzheimer's disease.
    Lancet Neurol. 2009;8:514.
    PubMed     Text format     Related articles   


    May 2009

  14. Confronting the crisis in dementia care.
    Lancet Neurol. 2009;8:413.
    PubMed     Text format     Related articles   


    February 2009
  15. BALLARD C , Hanney ML, Theodoulou M, Douglas S, et al
    The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.
    Lancet Neurol. 2009;8:151-7.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  16. BURNS A
    Alzheimer's disease: on the verges of treatment and prevention.
    Lancet Neurol. 2009;8:4-5.
    PubMed     Text format     Related articles   


  17. GOODMAN A
    Vladimir Hachinski: a pioneer in the field of stroke.
    Lancet Neurol. 2009;8:34.
    PubMed     Text format     Related articles   


    December 2008
  18. WILLIAMS R
    Richard Lipton: migraines, magnets, and much, much more.
    Lancet Neurol. 2008;7:1088.
    PubMed     Text format     Related articles   


  19. BURTON A
    YouTube-ing your way to neurological knowledge.
    Lancet Neurol. 2008;7:1086-7.
    PubMed     Text format     Related articles   


    November 2008
  20. BURNS A , Bernabei R, Bullock R, Jentoft AJ, et al
    Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
    Lancet Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available


  21. FARLOW MR
    The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease.
    Lancet Neurol. 2008.
    PubMed     Text format     Related articles   


    September 2008
  22. O'BRIEN JT
    A promising new treatment for Alzheimer's disease?
    Lancet Neurol. 2008;7:768-9.
    PubMed     Text format     Related articles   


    August 2008
  23. GAUTHIER S , Dubois B, Feldman H, Scheltens P, et al
    Revised research diagnostic criteria for Alzheimer's disease.
    Lancet Neurol. 2008;7:668-70.
    PubMed     Text format     Related articles   


    July 2008
  24. RELKIN NR
    Testing the mettle of PBT2 for Alzheimer's disease.
    Lancet Neurol. 2008.
    PubMed     Text format     Related articles   


  25. LANNFELT L , Blennow K, Zetterberg H, Batsman S, et al
    Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available


  26. WISNIEWSKI T , Konietzko U
    Amyloid-beta immunisation for Alzheimer's disease.
    Lancet Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available


  27. KALARIA RN , Maestre GE, Arizaga R, Friedland RP, et al
    Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.
    Lancet Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available


    June 2008
  28. AISEN PS
    Tarenflurbil: a shot on goal.
    Lancet Neurol. 2008;7:468-9.
    PubMed     Text format     Related articles   


    May 2008
  29. VELLAS B , Andrieu S, Sampaio C, Coley N, et al
    Endpoints for trials in Alzheimer's disease: a European task force consensus.
    Lancet Neurol. 2008;7:436-450.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  30. WILCOCK GK , Black SE, Hendrix SB, Zavitz KH, et al
    Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Lancet Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  31. EDVARDSSON D , Winblad B, Sandman P
    Person-centred care of people with severe Alzheimer's disease: current status and ways forward.
    Lancet Neurol. 2008;7:362-7.
    PubMed     Text format     Related articles    Abstract available


    February 2008
  32. DICHGANS M , Markus HS, Salloway S, Verkkoniemi A, et al
    Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
    Lancet Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  33. SCHNEIDER LS
    Does donepezil improve executive function in patients with CADASIL?
    Lancet Neurol. 2008;.
    PubMed     Text format     Related articles   


  34. THE LANCET NEUROLOGY
    Keeping track of patients with Alzheimer's disease.
    Lancet Neurol. 2008;7:113.
    PubMed     Text format     Related articles   


    January 2008
  35. ROWE CC , Ackerman U, Browne W, Mulligan R, et al
    Imaging of amyloid beta in Alzheimer's disease with (18)F-BAY94-9172, a novel PET tracer: proof of mechanism.
    Lancet Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  36. FRISONI GB
    Imaging of amyloid comes of age.
    Lancet Neurol. 2008;.
    PubMed     Text format     Related articles   


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: